Related Experiment Video
Updated: Jan 30, 2026

Classical Short-Delay Eyeblink Conditioning in One-Year-Old Children
Published on: September 1, 2018
Improved General and Height-Specific Quality of Life in Children With Short Stature After 1 Year on Growth Hormone
Laura G González Briceño1,2, Magali Viaud1,3, Jacques Beltrand1,3,4
1Pediatric Endocrinology, Diabetology and Gynecology Department, Hôpital Universitaire Necker-Enfants Malades [Assistance Publique Hôpitaux de Paris (AP-HP)], Paris, France.
Insights
Growth hormone (GH) treatment significantly improved children's emotional and social quality of life (QoL) after one year. Height gains correlated positively with QoL improvements, benefiting children with short stature.
Area of Science:
- Pediatrics
- Endocrinology
- Quality of Life Research
Background:
- Short stature in children can cause psychosocial distress and negatively impact quality of life (QoL).
- Growth hormone (GH) therapy is a potential intervention to normalize height and improve QoL.
Purpose of the Study:
- To evaluate general and height-specific QoL in children and adolescents with short stature after one year of GH treatment.
Main Methods:
- A prospective, single-center observational cohort study included 74 children (aged ≥ 4 years) treated with GH.
- Patients completed general (PedsQL 4.0) and height-specific (QoLiSSY) QoL questionnaires at baseline and after one year.
- Correlations between height gain and QoL improvements were analyzed.
Main Results:
- GH treatment led to significant improvements in self-reported emotional and social QoL.
- Parent-reported QoL also showed significant improvements in physical, emotional, and social domains.
- Height standard deviation score (SDS) gains positively correlated with QoL improvements from both self and parent reports.
Conclusions:
- One year of GH treatment significantly enhances emotional and social QoL in children with short stature.
- Both general and height-specific QoL measures indicate positive outcomes.
- The degree of height gain is associated with the extent of QoL improvement.
Objective:
Short stature in children and adolescents may lead to social and emotional stress, with negative effects on quality of life (QoL). GH treatment may improve QoL through height normalization. Our objective here was to evaluate general and height-specific QoL after 1 year of GH treatment.
Design:
Prospective, single-center, observational cohort study.
Methods:
Children ≥ 4 years of age starting GH at our center from 2012 to 2015 to treat short stature were studied. Patients with serious diseases, syndromic short stature, or developmental delay were excluded. At treatment initiation and 1 year later, patients and their parents completed the general PedsQL 4.0 and height-specific Quality of Life in Short Stature Youth (QoLiSSY) questionnaires. Correlations between self-report and parent-report scores and between height gain and QoL improvements were assessed based on Pearson correlation coefficients.
Results:
Seventy-four children (42 boys, 32 girls), median age (± SD), 10.2 ± 3.0 years (range, 4.1 to 16.6 years), were included. The self-report PedsQL indicated significant improvements in emotional (P = 0.02) and social (P = 0.03) QoL. As assessed by the QoLiSSY, children reported improvement of social QoL (+0.2 SD; P = 0.04), and parents reported improvement of children's physical (+0.1 SD; P < 0.0001), emotional (+0.3 SD; P < 0.0001), and social (+0.3 SD; P < 0.0001) QoL. Height SD score (SDS) gains showed moderate positive correlations with QoLISSY self-report score gains (R = 0.53, R2 = 0.28; P < 0.001) and QoLISSY parent-report gains (R = 0.60, R2 = 0.41; P < 0.00001).
Conclusions:
After 1 year of GH treatment, children had significant gains in emotional and social QoL, as assessed by a general self-report questionnaire and height-specific parent-report questionnaire.
Related Concept Videos
Nature and Nurture
Plant Hormones
Half-life of a Reaction
Characteristics of Life
Hormonal Regulation
Hormonal Regulation

